Could a common supplement calm ulcerative colitis flares?
NCT ID NCT04276740
First seen Jan 13, 2026 · Last updated May 23, 2026 · Updated 17 times
Summary
This study tests whether MitoQ, a mitochondrial antioxidant, can help people with moderate ulcerative colitis (UC) during a flare-up. About 79 adults with active UC will take either MitoQ or a placebo daily for 24 weeks, alongside standard steroid treatment. The goal is to see if MitoQ reduces inflammation and symptoms better than placebo alone.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ULCERATIVE COLITIS FLARE are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
NHS Lothian
Edinburgh, United Kingdom
Conditions
Explore the condition pages connected to this study.